YUTREPIA: A New Milestone in Pulmonary Arterial Hypertension Treatment
YUTREPIA: A New Milestone in Pulmonary Arterial Hypertension Treatment Introduction Pulmonary Arterial Hypertension (PAH) is a progressive and life-threatening condition that poses significant challenges in the medical community. The disease is characterized by high blood pressure in the arteries that supply the lungs, leading to symptoms such as shortness of breath, dizziness, and fatigue.…